This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Mar;144(3):652-3.

doi: 10.1053/j.gastro.2013.01.037. Epub 2013 Jan 25.

First-line eradication therapy for Helicobacter pylori: time for a change?

Alexander C Ford¹

Affiliations

PMID: 23357055
DOI: 10.1053/j.gastro.2013.01.037

Comment

First-line eradication therapy for Helicobacter pylori: time for a change?

Alexander C Ford. Gastroenterology. 2013 Mar.

. 2013 Mar;144(3):652-3.

doi: 10.1053/j.gastro.2013.01.037. Epub 2013 Jan 25.

Author

Alexander C Ford¹

Affiliation

¹ Leeds Gastroenterology Institute, Leeds Teaching Hospitals, Leeds, UK.

PMID: 23357055
DOI: 10.1053/j.gastro.2013.01.037

No abstract available

PubMed Disclaimer

Comment on

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Liou JM, Chen CC, Chen MJ, Chen CC, Chang CY, Fang YJ, Lee JY, Hsu SJ, Luo JC, Chang WH, Hsu YC, Tseng CH, Tseng PH, Wang HP, Yang UC, Shun CT, Lin JT, Lee YC, Wu MS; Taiwan Helicobacter Consortium. Liou JM, et al. Lancet. 2013 Jan 19;381(9862):205-13. doi: 10.1016/S0140-6736(12)61579-7. Epub 2012 Nov 16. Lancet. 2013. PMID: 23158886 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations